Vaccine Technologies Against Avian Influenza: Current Approaches and New Directions

被引：9

作者：

Ross, Kathleen A. ^{[1
]}

Huntimer, Lucas M. ^{[2
]}

Ramirez, Julia E. Vela ^{[1
]}

Adams, Justin R. ^{[1
]}

Carpenter, Susan L. ^{[3
]}

Kohut, Marian L. ^{[4
]}

Bronich, Tatiana ^{[5
]}

Webby, Richard ^{[6
]}

Legge, Kevin L. ^{[7
]}

Mallapragada, Surya K. ^{[1
]}

Wannemuehler, Michael J. ^{[2
]}

Narasimhan, Balaji ^{[1
]}

机构：

[1] Iowa State Univ, Dept Chem & Biol Engn, Ames, IA 50011 USA

[2] Iowa State Univ, Dept Vet Microbiol & Prevent Med, Ames, IA 50011 USA

[3] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA

[4] Iowa State Univ, Dept Kinesiol, Ames, IA 50011 USA

[5] Univ Nebraska Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA

[6] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA

[7] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA

来源：

JOURNAL OF BIOMEDICAL NANOTECHNOLOGY | 2014年 / 10卷 / 09期

关键词：

H5N1; Highly Pathogenic Avian Influenza; Pandemic; Vaccine; Antiviral; VIRUS-LIKE-PARTICLES; T-CELL RESPONSES; REACTIVE IMMUNE-RESPONSES; PRIME-BOOST VACCINATION; AGE-RELATED DEFECTS; 2009 PANDEMIC H1N1; B SURFACE-ANTIGEN; H5N1; INFLUENZA; A H5N1; DENDRITIC CELLS;

D O I：

10.1166/jbn.2014.1983

中图分类号：

TB3 [工程材料学];

学科分类号：

0805 ; 080502 ;

摘要：

The potential epidemiological human pandemic resulting from highly pathogenic avian influenza (HPAI) H5N1 has been studied extensively since the identification of the virus in the Guangdong province of China. The majority of research has focused on the unique and severe histopathological lesions induced by the virus. The severe pathological presentation of these infections has also prompted interest in identifying preventive and therapeutic approaches against HPAI. The potential severity of a HPAI pandemic and the efforts to identify effective intervention strategies have led to many novel discoveries in vaccine and antiviral development that are critically examined in this review.

引用

页码：2261 / 2294

页数：34

共 334 条

[1] Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279
[2] A universal epitope-based influenza vaccine and its efficacy against H5N1
Adar, Y.
Singer, Y.
Levi, R.
Tzehoval, E.
Perk, S.
Banet-Noach, C.
Nagar, S.
Amon, R.
Ben-Yedidia, T.
[J]. VACCINE, 2009, 27 (15) : 2099 - 2107
[3] Intranasal administration of adjuvant-combined recombinant influenza virus HA vaccine protects mice from the lethal H5N1 virus infection
Asahi-Ozaki, Yasuko
Itamura, Shigeyuki
Ichinohe, Takeshi
Strong, Peter
Tamura, Shin-ichi
Takahashi, Hidehiro
Sawa, Hirofumi
Moriyama, Masami
Tashiro, Masato
Sata, Tetsutaro
Kurata, Takeshi
Hasegawa, Hideki
[J]. MICROBES AND INFECTION, 2006, 8 (12-13) : 2706 - 2714
[4] A novel combined adjuvant for nasal delivery elicits mucosal immunity to influenza in aging
Asanuma, Hideki
Zamri, Normaiza Binti
Sekine, Shinichi
Fukuyama, Yoshiko
Tokuhara, Daisuke
Gilbert, Rebekah S.
Fukuiwa, Tatsuya
Fujihashi, Keiko
Sata, Tetsutaro
Tashiro, Masato
Fujihashi, Kohtaro
[J]. VACCINE, 2012, 30 (04) : 803 - 812
[5] MF59®-Adjuvanted H5N1 Vaccine Induces Immunologic Memory and Heterotypic Antibody Responses in Non-Elderly and Elderly Adults
Banzhoff, Angelika
Gasparini, Roberto
Laghi-Pasini, Franco
Staniscia, Tommaso
Durando, Paolo
Montomoli, Emanuele
Capecchi, Pamela
di Giovanni, Pamela
Sticchi, Laura
Gentile, Chiara
Hilbert, Anke
Brauer, Volker
Tilman, Sandrine
Podda, Audino
[J]. PLOS ONE, 2009, 4 (02):
[6] Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus
Baskin, Carole R.
Bielefeldt-Ohmann, Helle
Tumpey, Terrence M.
Sabourin, Patrick J.
Long, James P.
Garcia-Sastre, Adolfo
Tolnay, Airn-E.
Albrecht, Randy
Pyles, John A.
Olson, Pam H.
Aicher, Lauri D.
Rosenzweig, Elizabeth R.
Murali-Krishna, Kaja
Clark, Edward A.
Kotur, Mark S.
Fornek, Jamie L.
Proll, Sean
Palermo, Robert E.
Sabourin, Carol L.
Katze, Michael G.
[J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (09) : 3455 - 3460
[7] In Vivo Studies on the Effect of Co-Encapsulation of CpG DNA and Antigen in Acid-Degradable Microparticle Vaccines
Beaudette, Tristan T.
Bachelder, Eric M.
Cohen, Joel A.
Obermeyer, Allie C.
Broaders, Kyle E.
Frechet, Jean M. J.
Kang, Eun-Suk
Mende, Ines
Tseng, William W.
Davidson, Matthew G.
Engleman, Edgar G.
[J]. MOLECULAR PHARMACEUTICS, 2009, 6 (04) : 1160 - 1169
[8] Safety and Immunogenicity of Multiple and Higher Doses of an Inactivated Influenza A/H5N1 Vaccine
Beigel, John H.
Voell, Jocelyn
Huang, Chiung-yu
Burbelo, Peter D.
Lane, H. Clifford
[J]. JOURNAL OF INFECTIOUS DISEASES, 2009, 200 (04) : 501 - 509
[9] Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine
Belshe, RB
Gruber, WC
Mendelman, PM
Cho, I
Reisinger, K
Block, SL
Wittes, J
Iacuzio, D
Piedra, P
Treanor, J
King, J
Kotloff, K
Bernstein, DI
Hayden, FG
Zangwill, K
Yan, LH
Wolff, M
[J]. JOURNAL OF PEDIATRICS, 2000, 136 (02) : 168 - 175
[10] Live attenuated versus inactivated influenza vaccine in infants and young children
Belshe, Robert B.
Edwards, Kathryn M.
Vesikari, Timo
Black, Steven V.
Walker, Robert E.
Hultquist, Micki
Kemble, George
Connor, Edward M.
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07) : 685 - 696

← 1 2 3 4 5 6 7 8 9 10 →